Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.
about
Risk of new-onset diabetes associated with statin useDo statins impair cognition? A systematic review and meta-analysis of randomized controlled trialsChallenges and opportunities in accessing trial data: an example from statin primary prevention trials.Revisiting the J shaped curve, exploring the association between cardiovascular risk factors and concurrent depressive symptoms in patients with cardiometabolic disease: Findings from a large cross-sectional study.Benefit-risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients.Statin-induced calcific Achilles tendinopathy in rats: comparison of biomechanical and histopathological effects of simvastatin, atorvastatin and rosuvastatin.Cardiovascular risk assessment and lipid modification: NICE guideline.Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate.Communicating statin evidence to support shared decision-making.Myopathy in older people receiving statin therapy: a systematic review and meta-analysis.Effects of simvastatin and atorvastatin on biochemical and hematological markers in patients with risk of cardiovascular diseases.Systemic differences in serum metabolome: a cross sectional comparison of women with localised and widespread pain and controls.Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial.Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment.Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study.Non-traditional dosing of statins in statin-intolerant patients-is it worth a try?Statin treatment is associated with a decreased risk of active tuberculosis: an analysis of a nationally representative cohort.Medication-related fall incidents in an older, ambulant population: the B-PROOF study.Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies.Statins and their effect on cognition: Let's clear up the confusion.Statins and their increased risk of inducing diabetes.Bacteriostatic Effect of Simvastatin on Selected Oral Streptococci in Vitro.Comprehensive efforts to increase adherence to statin therapy.Cost effectiveness of case-finding strategies for primary prevention of cardiovascular disease: a modelling study.Statin use and cognitive function in middle-aged adults with type 1 diabetes.Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome.Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism.Lipophilic Statins and Aldosterone Secretion: A Bridge Too Far?Statins and cognitive impairment.Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats.A Possible Case of Statin-Induced Ichthyosis in an Elderly Woman.The obesity epidemic and rising diabetes incidence in a low-income racially diverse southern US cohort.Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis.Risk of new-onset diabetes among patients treated with statins according to hypertension and gender: Results from a nationwide health-screening cohort.Cholesterol, not just cardiovascular risk, is important in deciding who should receive statin treatment.[Statin intolerance and associated muscular dysfunctions].Pharmacometabolomic signature links simvastatin therapy and insulin resistance.Almonds and Cardiovascular Health: A Review.Statin-associated myopathy. Assessment of frequency based on data of all statutory health insurance funds in Germany.The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan.
P2860
Q26771800-77EFFF3F-AA20-4E2D-B145-025295113E3FQ28085282-D84C786C-50A3-4F32-A1C2-E8CDA1D949A1Q33622465-45111ADF-AF6F-4C88-82CF-5413327C9436Q34738760-1613FCFF-7B46-4ECB-91F5-C22D6826869AQ35508337-E5FE1909-E79E-4054-AAFB-9181FAA5E50DQ35746689-3EF309B3-08E5-4B2A-AC10-C893236221ABQ35795487-DD1E80C6-A017-41D7-BEEB-010FAD4E527AQ35894747-6D39E9FE-833C-450D-8111-E74279854FCCQ35980419-9C24C498-B179-4BDF-B2A0-42FBE1F1DF4BQ36072457-12C80313-9359-4A96-A05B-88B61EF2B8DEQ36183390-581799FD-42C1-44E7-AD3E-1E80EB9CC5C3Q36237641-AF29093B-1314-441B-821F-98CE2E7BD1A0Q36251159-2BDF32C3-B3B3-4477-AD2A-E06B5A90B9AFQ37310533-B4C8E0B5-AE1B-4205-8AB7-323611AE250CQ37612171-FD1E9C81-D36F-4C24-A7B5-8692402CADADQ38272551-FD686B09-85D4-47B6-9325-9A71DB0C0E2BQ38409346-A1C3A950-3875-4A84-A145-ECDD402DF29FQ38417824-444CB975-81AF-4A4F-A1C3-F6B5EE5DBF74Q38538716-1925A92A-443B-419A-A851-1FA42D4EFB38Q38543522-07A893E2-3932-4AD6-BD83-C026D2CCC772Q38599323-A4CB9BAE-80E1-4B06-A146-4A65C8815693Q38752447-6ECA3AAE-A106-4092-BF74-0306F0EFD411Q39080414-3F5B90F8-F46E-465F-BC2A-D0C5AC21474AQ39207492-4CA05C3C-6558-4AA5-887D-E03402F648BDQ40128220-C4FF8D1C-1034-4220-90F5-D77560F2D60AQ41093207-A28601AD-4E6B-4A7C-B562-39F4E481B3DEQ41336155-6DB4E3D7-5183-4804-843C-2B0BE51223D8Q42380513-DC306D53-EB42-4D8E-93F8-434DA756BAA4Q42789289-8BFF94A2-274E-4C97-84E3-AC9DE826FDBCQ47113147-C24AD1CC-99E3-4212-9C68-19FB3F4880A7Q48138182-88A629FE-6AE9-4824-A7BD-4D2CFAB754CAQ48258995-A57B40F9-58FB-49A5-97EB-3C87B74C905AQ52317633-E072458F-5063-4BD9-9690-477247C83650Q52598786-8EDC8613-7D76-43F3-91AD-B2114A5653CAQ53592893-ECB810DD-5EF3-4574-A8F7-0D57E1911E95Q53649484-10A03729-2344-4FB0-94BE-885CD24D45CAQ53755580-C04398EA-2461-40D0-9E24-13239153AAA1Q55109092-7462A5BF-3762-4609-B5FD-A3F9DE272584Q55129505-41F3289C-A9E9-4C79-BC69-9617A5D8A09CQ55237417-1A30F7FC-9B3D-4BF6-BB48-B9D6F56F877B
P2860
Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Unintended effects of statins ...... atic review and meta-analysis.
@ast
Unintended effects of statins ...... atic review and meta-analysis.
@en
Unintended effects of statins ...... atic review and meta-analysis.
@nl
type
label
Unintended effects of statins ...... atic review and meta-analysis.
@ast
Unintended effects of statins ...... atic review and meta-analysis.
@en
Unintended effects of statins ...... atic review and meta-analysis.
@nl
prefLabel
Unintended effects of statins ...... atic review and meta-analysis.
@ast
Unintended effects of statins ...... atic review and meta-analysis.
@en
Unintended effects of statins ...... atic review and meta-analysis.
@nl
P2093
P2860
P31
P921
P356
P1433
P1476
Unintended effects of statins ...... atic review and meta-analysis.
@en
P2093
Alma Adler
Ana Filipa Macedo
Fiona Claire Taylor
Juan P Casas
Shah Ebrahim
P2860
P2888
P356
10.1186/1741-7015-12-51
P407
P577
2014-03-22T00:00:00Z